PT/INR Reference Interval IN Healthy Volunteers
NCT02319109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154
Last updated 2015-01-22
Summary
This is a prospective, single-center study in healthy volunteers to establish a PT/INR reference interval for the Microvisk International Normalized Ratio (INR) Test System. The primary objective of this study is to establish the reference interval for the measurement of prothrombin time (PT/INR) using the Microvisk INR Test System. The second objective is to evaluate the safety of the device.
Conditions
- Healthy
Sponsors & Collaborators
-
Microvisk Technologies Ltd
lead INDUSTRY
Principal Investigators
-
Helen Stacey, MD, PhD · Diablo Clinical Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
The Home INR Study
NCT00032591 ·Status: COMPLETED ·Phase: PHASE4
-
International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly
NCT02614573 ·Status: COMPLETED ·Phase: NA
-
Patient Self Testing of Warfarin Therapy
NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
NCT02392104 ·Status: COMPLETED ·Phase: NA
-
User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01036646 ·Status: COMPLETED
-
Microvisk Continuous Blood Donation Study
NCT06648837 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
NCT00288808 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)
NCT00933738 ·Status: COMPLETED
-
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System
NCT00978445 ·Status: COMPLETED ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers
NCT02357524 ·Status: COMPLETED ·Phase: PHASE1
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity
NCT01037270 ·Status: COMPLETED
-
A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements
NCT02205827 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)
NCT03682419 ·Status: COMPLETED ·Phase: NA
-
Fiix-prothrombin Time for Monitoring Warfarin
NCT01565239 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
NCT00660946 ·Status: COMPLETED
-
Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study
NCT06645275 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?
NCT00990158 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects
NCT02461914 ·Status: COMPLETED ·Phase: PHASE1
-
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295 ·Status: RECRUITING ·Phase: PHASE3
-
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153 ·Status: COMPLETED
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
NCT00830570 ·Status: COMPLETED
-
Prevention of Recurrent Venous Thromboembolism (PREVENT)
NCT00000614 ·Status: COMPLETED ·Phase: PHASE3